Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 548

1.

Erythropoietin hyporesponsiveness: from iron deficiency to iron overload.

Tarng DC, Huang TP, Chen TW, Yang WC.

Kidney Int Suppl. 1999 Mar;69:S107-18. Review.

PMID:
10084294
3.
4.
5.

Is it time for a paradigm shift? Is erythropoietin deficiency still the main cause of renal anaemia?

Eschbach JW, Varma A, Stivelman JC.

Nephrol Dial Transplant. 2002;17 Suppl 5:2-7.

PMID:
12091599
6.

Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure.

Ahluwalia N, Skikne BS, Savin V, Chonko A.

Am J Kidney Dis. 1997 Oct;30(4):532-41.

PMID:
9328369
7.

Managing erythropoietin hyporesponsiveness.

Kwack C, Balakrishnan VS.

Semin Dial. 2006 Mar-Apr;19(2):146-51. Review.

PMID:
16551293
8.
9.

[Can anemia be corrected in hemodialysis patients with thalassaemia minor? ].

Di Iorio B, Guastaferro P, Gironda A, Marano V, Morrongiello L, Cillo N, Zito B, Nigro F, Frieri A, Rubino R, Bellizzi V.

G Ital Nefrol. 2002 Sep-Oct;19(5):552-9. Italian.

PMID:
12439845
10.
11.

Efficacy of a low-dose intravenous iron sucrose regimen in peritoneal dialysis patients.

Dittrich E, Schillinger M, Sunder-Plassmann G, Hörl WH, Vychytil A.

Perit Dial Int. 2002 Jan-Feb;22(1):60-6.

PMID:
11929146
12.

Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.

Mittman N, Sreedhara R, Mushnick R, Chattopadhyay J, Zelmanovic D, Vaseghi M, Avram MM.

Am J Kidney Dis. 1997 Dec;30(6):912-22.

PMID:
9398141
13.

[Clinical and economic significance of iron replacement in anemia treated with recombinant human erythropoietin in patients on hemodialysis].

Vanková S, Safárová R, Horácková M, Herink J, Rychlík I, Bahbouh R, Půtová I.

Cas Lek Cesk. 2001 Apr 12;140(7):209-13. Czech.

PMID:
11374225
14.
15.

Iron status and iron supplementation in peritoneal dialysis patients.

Vychytil A, Haag-Weber M.

Kidney Int Suppl. 1999 Mar;69:S71-8. Review.

PMID:
10084290
16.

Intravenous ascorbic acid administration for erythropoietin-hyporesponsive anemia in iron loaded hemodialysis patients.

Sezer S, Ozdemir FN, Yakupoglu U, Arat Z, Turan M, Haberal M.

Artif Organs. 2002 Apr;26(4):366-70.

PMID:
11952508
17.

Strategies for iron supplementation: oral versus intravenous.

Macdougall IC.

Kidney Int Suppl. 1999 Mar;69:S61-6. Review.

PMID:
10084288
18.

[Anemia in peritoneal dialysis patients].

Lausević M, Nesić V, Jovanović N, Stojimirović B.

Srp Arh Celok Lek. 2006 Mar-Apr;134(3-4):133-7. Serbian.

19.

An indistinct balance: the safety and efficacy of parenteral iron therapy.

Besarab A, Frinak S, Yee J.

J Am Soc Nephrol. 1999 Sep;10(9):2029-43. Review.

20.

Supplemental Content

Support Center